EU and US could reach trade deal this weekend - Reuters
Robert Edward Hensley, Executive Vice President and Chief Investment Officer of Globe Life Inc. (NYSE:GL), recently sold 1,610 shares of the company’s common stock. The transaction, which took place on March 4, 2025, was executed at an average price of $124.815 per share, amounting to a total sale value of $200,952. The sale comes as Globe Life, currently valued at $10.6 billion, maintains a strong financial position with an "GREAT" overall health score according to InvestingPro analysis.
Following this transaction, Hensley holds 10,193 shares of Globe Life’s common stock directly. The sale was reported in a Form 4 filing with the Securities and Exchange Commission, which was signed by an attorney-in-fact on March 5, 2025. While this insider sale occurred, it’s worth noting that management has been actively buying back shares, and the company has maintained dividend payments for 55 consecutive years. InvestingPro analysis indicates the stock is currently undervalued, with additional insights available in the comprehensive Pro Research Report, one of 1,400+ detailed company analyses available to subscribers.
In other recent news, Globe Life Inc. reported its fourth-quarter 2024 earnings, surpassing analysts’ expectations with an earnings per share (EPS) of $3.14, slightly above the forecasted $3.12. However, the company’s revenue fell short at $1.47 billion, compared to the anticipated $1.48 billion. The company’s full-year earnings also showed strong performance, with a 12% increase in EPS to $12.37, exceeding both CFRA’s estimate of $12.29 and the consensus estimate of $12.34. CFRA analyst Catherine Seifert raised the price target for Globe Life shares from $118.00 to $130.00, maintaining a Hold rating, reflecting a valuation based on projected earnings per share. Meanwhile, TD Cowen reiterated its Buy rating on Globe Life shares, maintaining a price target of $168.00, citing positive trends in new business and capital. Globe Life also announced the expansion of its board of directors, appointing two new independent directors, Matthew J. Adams and Philip M. Jacobs. These developments highlight Globe Life’s ongoing efforts in governance, financial growth, and strategic planning.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.